MENU
INMB
AS OF
Nov 13 closing price
Price
$1.43
Change
-$0.09 (-5.92%)
Capitalization
38.02M
104 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
INMB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

INmune Bio (INMB) Earnings Date & Reports

INmune Bio Inc is a clinical-stage biotechnology company... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

INMB is expected to report earnings to rise 20.83% to -28 cents per share on February 26

INmune Bio INMB Stock Earnings Reports
Q4'25
Est.
$-0.29
Q3'25
Beat
by $0.09
Q2'25
Missed
by $0.65
Q1'25
Beat
by $0.06
Q4'24
Beat
by $0.15
The last earnings report on October 30 showed earnings per share of -23 cents, beating the estimate of -33 cents. With 325.27K shares outstanding, the current market capitalization sits at 38.02M.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
INMB
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. INMB showed earnings on October 30, 2025. You can read more about the earnings report here.
View AI-Driven Trading for INMB
A.I. Advisor
published General Information

General Information

a developer of therapies that harness the patient's immune system to treat cancer

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
225 NE Mizner Boulevard
Phone
+1 858 964-3720
Employees
17
Web
https://www.inmunebio.com